Maternal and neonatal outcomes | Without dyslipidemia | Â | Dyslipidemia | |
---|---|---|---|---|
 |  | OR (95%CI) | P-values | |
Gestational hypertension | Â | Â | Â | Â |
 Model 1 | reference |  | 2.171 (1.066–4.421) | 0.033* |
 Model 2 | reference |  | 2.092 (1.017–4.301) | 0.045* |
 Model 3 | reference |  | 2.810 (1.321–5.975) | 0.007* |
 Model 4 | reference |  | 1.996 (0.913–4.364) | 0.083 |
Preeclampsia/Eclampsia | Â | Â | Â | Â |
 Model 1 | reference |  | 2.400 (1.197–4.813) | 0.014* |
 Model 2 | reference |  | 2.366 (1.171–4.777) | 0.016* |
 Model 3 | reference |  | 1.878 (0.835–4.225) | 0.128 |
 Model 4 | reference |  | 1.557 (0.680–3.568) | 0.295 |
GDM | Â | Â | Â | Â |
 Model 1 | reference |  | 1.870 (1.245–2.809) | 0.003* |
 Model 2 | reference |  | 1.609 (1.059–2.446) | 0.026* |
 Model 3 | reference |  | 1.702 (1.101–2.632) | 0.017* |
 Model 4 | reference |  | 1.427 (0.911–2.325) | 0.121 |
Low birth weight | Â | Â | Â | Â |
 Model 1 | reference |  | 2.462 (1.070–5.668) | 0.034* |
 Model 2 | reference |  | 2.422 (1.043–5.624) | 0.040* |
 Model 3 | reference |  | 2.114 (0.838–5.332) | 0.113 |
 Model 4 | reference |  | 1.923 (0.744–4.976) | 0.177 |